Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

150.36
+2.181.47%
Pre-market: 151.571.21+0.80%05:04 EDT
Volume:2.08M
Turnover:312.18M
Market Cap:286.89B
PE:21.03
High:150.75
Open:150.25
Low:149.56
Close:148.18
52wk High:170.46
52wk Low:97.72
Shares:1.91B
Float Shares:1.82B
Volume Ratio:1.44
T/O Rate:0.11%
Dividend:4.67
Dividend Rate:3.10%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.22
PE(LYR):21.03

Loading ...

Live from Davos: YIDU TECH (02158), Brunei Ministry of Health, and Novartis Foundation Announce Launch of AI-Driven National Cardiovascular Disease Prevention and Control Project

Stock News
·
Jan 23

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 21

Novartis Stock (NVS) Holds on Upbeat View of Tariff Exposure amid U.S.-EU Tension

TIPRANKS
·
Jan 20

DAVOS: Novartis Expects No Impact From Potential New U.S. Tariffs -- Market Talk

Dow Jones
·
Jan 20

Novartis receives FDA Breakthrough Therapy designation for ianalumab

TIPRANKS
·
Jan 17

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

Dow Jones
·
Jan 17

Novartis enters worldwide license agreement with PepLib

TIPRANKS
·
Jan 14

FDA Outlines CMC Flexibility for Cell/Gene Therapies, Potentially Benefiting Novartis and Pfizer

Deep News
·
Jan 14

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 13

SciNeuro and Novartis Ink $1.7 Billion Licensing Deal to Co-develop Alzheimer's Treatment

Deep News
·
Jan 12

Novartis to add radioligand therapy manufacturing facility in Florida

TIPRANKS
·
Jan 09

European Pharma Stocks Follow Asian, U.S. Peers Higher -- Market Talk

Dow Jones
·
Jan 07

Novartis Raised to Equal-Weight From Underweight by Barclays

Dow Jones
·
Jan 07

Heard on the Street: Big Pharma Has More Going for It Than Obesity Drugs -- WSJ

Dow Jones
·
Jan 06

The Year-End 2025 Biotech Rally And What It Means For 2026

Benzinga_recent_news
·
Dec 31, 2025

What's Going On With Royalty Pharma Stock Wednesday?

Benzinga
·
Dec 31, 2025

Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026

MT Newswires Live
·
Dec 31, 2025

Exclusive-Drugmakers Raising Prices Include Pfizer, Sanofi, GSK, Novartis and Boehringer Ingelheim, Which Have Pricing Deals With Trump Admin

THOMSON REUTERS
·
Dec 31, 2025

Merck (MRK.US), Bristol-Myers Squibb (BMY.US), and Other Pharma Giants Agree to Lower U.S. Drug Prices in Exchange for Tariff Exemptions and Policy Support

Stock News
·
Dec 20, 2025

Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies

MT Newswires Live
·
Dec 20, 2025